AHMEDABAD, 7 JANUARY Zydus Life: US FDA Accepts For Filing and Grants Priority Review to Zydus Life’s US-based Arm & Fortress Bio’s NDA for CUTX-101. (Positive) Jubilant Food: Company projects 56.2% year-on-year growth in Q3 revenue (Positive) Akzo Nobel: Parent entity, Akzo Nobel NV (ANNV), has proposed a strategic evaluationContinue Reading